| Item Type | Name |
|
Concept
|
Ranolazine
|
|
Concept
|
Walk Test
|
|
Concept
|
Sildenafil Citrate
|
|
Concept
|
Vardenafil Dihydrochloride
|
|
Concept
|
Administration, Cutaneous
|
|
Concept
|
Analysis of Variance
|
|
Concept
|
Administration, Oral
|
|
Concept
|
Administration, Topical
|
|
Concept
|
Adrenergic beta-Agonists
|
|
Concept
|
Adrenergic beta-Antagonists
|
|
Concept
|
Anemia
|
|
Concept
|
Anemia, Aplastic
|
|
Concept
|
Anemia, Hemolytic
|
|
Concept
|
Angina Pectoris
|
|
Concept
|
Angina, Unstable
|
|
Concept
|
Angiocardiography
|
|
Concept
|
Angiography
|
|
Concept
|
Angioedema
|
|
Concept
|
Angioplasty, Balloon
|
|
Concept
|
Angiotensin-Converting Enzyme Inhibitors
|
|
Concept
|
Animals
|
|
Concept
|
Anti-Arrhythmia Agents
|
|
Concept
|
Age Factors
|
|
Concept
|
Anticoagulants
|
|
Concept
|
Antihypertensive Agents
|
|
Concept
|
Hypolipidemic Agents
|
|
Concept
|
Calcium
|
|
Concept
|
Calcium Channel Agonists
|
|
Concept
|
Calcium Channel Blockers
|
|
Concept
|
Ambulatory Care
|
|
Concept
|
American Heart Association
|
|
Concept
|
Activities of Daily Living
|
|
Concept
|
Acute Disease
|
|
Concept
|
Amino Alcohols
|
|
Concept
|
African Americans
|
|
Concept
|
Adenosine
|
|
Concept
|
Cardiac Output
|
|
Concept
|
Cardiac Pacing, Artificial
|
|
Concept
|
Cardiac Volume
|
|
Concept
|
Cardiography, Impedance
|
|
Concept
|
Cardiotonic Agents
|
|
Concept
|
Cardiovascular Agents
|
|
Concept
|
Blood Flow Velocity
|
|
Concept
|
Blood Gas Analysis
|
|
Concept
|
Blood Glucose
|
|
Concept
|
Blood Pressure
|
|
Concept
|
Body Weight
|
|
Concept
|
3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester
|
|
Concept
|
Catecholamines
|
|
Concept
|
Bradycardia
|
|
Concept
|
Delayed-Action Preparations
|
|
Concept
|
Chronic Disease
|
|
Concept
|
Coronary Artery Disease
|
|
Concept
|
Coronary Circulation
|
|
Concept
|
Coronary Disease
|
|
Concept
|
Cineangiography
|
|
Concept
|
Circadian Rhythm
|
|
Concept
|
Clinical Trials as Topic
|
|
Concept
|
Diabetes Mellitus
|
|
Concept
|
Diabetes Mellitus, Type 2
|
|
Concept
|
Diabetic Angiopathies
|
|
Concept
|
Exercise Test
|
|
Concept
|
Exercise Therapy
|
|
Concept
|
Endothelium, Vascular
|
|
Concept
|
Femoral Artery
|
|
Concept
|
Femoral Vein
|
|
Concept
|
Dose-Response Relationship, Drug
|
|
Concept
|
Double-Blind Method
|
|
Concept
|
Drug Administration Schedule
|
|
Concept
|
Epinephrine
|
|
Concept
|
Fibrinolytic Agents
|
|
Concept
|
Drug Combinations
|
|
Concept
|
Drug Evaluation
|
|
Concept
|
Drug Therapy
|
|
Concept
|
Drug Therapy, Combination
|
|
Concept
|
Erythrocytes
|
|
Concept
|
Dyspnea
|
|
Concept
|
Echocardiography
|
|
Concept
|
Estradiol
|
|
Concept
|
Electrocardiography
|
|
Concept
|
Histamine
|
|
Concept
|
Guinea Pigs
|
|
Concept
|
Headache
|
|
Concept
|
Hospitalization
|
|
Concept
|
Health Status
|
|
Concept
|
Heart
|
|
Concept
|
Heart Aneurysm
|
|
Concept
|
Heart Atria
|
|
Concept
|
Humans
|
|
Concept
|
Cardiac Catheterization
|
|
Concept
|
Heart Conduction System
|
|
Concept
|
Cardiomegaly
|
|
Concept
|
Heart Function Tests
|
|
Concept
|
Heart Neoplasms
|
|
Concept
|
Heart Rate
|
|
Concept
|
Heart Septal Defects, Atrial
|
|
Concept
|
Heart Ventricles
|
|
Concept
|
Hydralazine
|
|
Concept
|
Hydrocortisone
|
|
Concept
|
Hydroxybutyrate Dehydrogenase
|
|
Concept
|
Hemodynamics
|
|
Concept
|
Lidocaine
|
|
Concept
|
Hemoglobins
|
|
Concept
|
Hemorrhage
|
|
Concept
|
Gastrointestinal Hemorrhage
|
|
Concept
|
Cholesterol, LDL
|
|
Concept
|
Glomerular Filtration Rate
|
|
Concept
|
Glucose
|
|
Concept
|
Liver Diseases
|
|
Concept
|
Long-Term Care
|
|
Concept
|
Kinetics
|
|
Concept
|
Lung Diseases
|
|
Concept
|
Lactates
|
|
Concept
|
Granuloma
|
|
Concept
|
Inflammation
|
|
Concept
|
Infusions, Intra-Arterial
|
|
Concept
|
Infusions, Intravenous
|
|
Concept
|
Leg
|
|
Concept
|
Infusions, Parenteral
|
|
Concept
|
Injections, Intravenous
|
|
Concept
|
Length of Stay
|
|
Concept
|
Insulin
|
|
Concept
|
Nifedipine
|
|
Concept
|
Muscle Relaxation
|
|
Concept
|
Muscle, Smooth, Vascular
|
|
Concept
|
Nigeria
|
|
Concept
|
Nitrates
|
|
Concept
|
Nitrendipine
|
|
Concept
|
Nitric Oxide
|
|
Concept
|
Myocardial Contraction
|
|
Concept
|
Myocardial Infarction
|
|
Concept
|
Myocardial Revascularization
|
|
Concept
|
Myocardium
|
|
Concept
|
Myxoma
|
|
Concept
|
Necrosis
|
|
Concept
|
Nutritive Value
|
|
Concept
|
Obesity
|
|
Concept
|
Isoproterenol
|
|
Concept
|
Isosorbide
|
|
Concept
|
Isosorbide Dinitrate
|
|
Concept
|
Nerve Growth Factors
|
|
Concept
|
Tissue Plasminogen Activator
|
|
Concept
|
Platelet Aggregation Inhibitors
|
|
Concept
|
Plethysmography, Impedance
|
|
Concept
|
Metoprolol
|
|
Concept
|
Pleural Effusion
|
|
Concept
|
Phenyl Ethers
|
|
Concept
|
Mitochondria, Heart
|
|
Concept
|
Mitral Valve
|
|
Concept
|
Phosphodiesterase Inhibitors
|
|
Concept
|
Phosphoric Diester Hydrolases
|
|
Concept
|
Postoperative Care
|
|
Concept
|
Potassium
|
|
Concept
|
Monitoring, Physiologic
|
|
Concept
|
Practolol
|
|
Concept
|
Motion Pictures
|
|
Concept
|
Physical Endurance
|
|
Concept
|
Practice Patterns, Physicians'
|
|
Concept
|
Predictive Value of Tests
|
|
Concept
|
Pregnancy Complications, Cardiovascular
|
|
Concept
|
Mouth Floor
|
|
Concept
|
Papillary Muscles
|
|
Concept
|
Piperazines
|
|
Concept
|
Regional Blood Flow
|
|
Concept
|
Registries
|
|
Concept
|
Sarcoidosis
|
|
Concept
|
Patient Transfer
|
|
Concept
|
Retrospective Studies
|
|
Concept
|
Pentaerythritol Tetranitrate
|
|
Concept
|
Rheumatoid Factor
|
|
Concept
|
Rheumatoid Nodule
|
|
Concept
|
Sensitivity and Specificity
|
|
Concept
|
Ricin
|
|
Concept
|
Serotonin
|
|
Concept
|
Severity of Illness Index
|
|
Concept
|
Risk
|
|
Concept
|
Risk Factors
|
|
Concept
|
Pericarditis, Constrictive
|
|
Concept
|
Pericardium
|
|
Concept
|
Thromboembolism
|
|
Concept
|
Thrombophlebitis
|
|
Concept
|
Thrombosis
|
|
Concept
|
Ticlopidine
|
|
Concept
|
Syncope
|
|
Concept
|
Syndrome
|
|
Concept
|
Pyridines
|
|
Concept
|
Pyrrolidines
|
|
Concept
|
Systole
|
|
Concept
|
Tachycardia
|
|
Concept
|
Tachycardia, Sinus
|
|
Concept
|
Quality of Life
|
|
Concept
|
Technetium
|
|
Concept
|
Rabbits
|
|
Concept
|
Radiography
|
|
Concept
|
Radionuclide Angiography
|
|
Concept
|
Radionuclide Imaging
|
|
Concept
|
Tetrahydronaphthalenes
|
|
Concept
|
Random Allocation
|
|
Concept
|
Exercise
|
|
Concept
|
Receptors, Adrenergic, beta
|
|
Concept
|
Recurrence
|
|
Concept
|
17-Hydroxycorticosteroids
|
|
Concept
|
Spironolactone
|
|
Concept
|
Spleen
|
|
Concept
|
Splenomegaly
|
|
Concept
|
3',5'-Cyclic-GMP Phosphodiesterases
|
|
Concept
|
Electrocardiography, Ambulatory
|
|
Concept
|
Nisoldipine
|
|
Concept
|
Reproducibility of Results
|
|
Concept
|
Bepridil
|
|
Concept
|
Calcium Channels
|
|
Concept
|
Defibrillators, Implantable
|
|
Concept
|
Stroke Volume
|
|
Concept
|
Cohort Studies
|
|
Concept
|
Isradipine
|
|
Concept
|
Amlodipine
|
|
Concept
|
Clinical Trials, Phase I as Topic
|
|
Concept
|
Clinical Trials, Phase II as Topic
|
|
Concept
|
Hypertrophy, Left Ventricular
|
|
Concept
|
Treatment Outcome
|
|
Concept
|
Valsalva Maneuver
|
|
Concept
|
Vanilmandelic Acid
|
|
Concept
|
Vascular Patency
|
|
Concept
|
Vascular Resistance
|
|
Concept
|
Vasoconstriction
|
|
Concept
|
Vasoconstrictor Agents
|
|
Concept
|
Guidelines as Topic
|
|
Concept
|
Practice Guidelines as Topic
|
|
Concept
|
Vasodilation
|
|
Concept
|
Vasodilator Agents
|
|
Concept
|
Ventricular Fibrillation
|
|
Concept
|
Coronary Angiography
|
|
Concept
|
Hospital Mortality
|
|
Concept
|
Disease Progression
|
|
Concept
|
Risk Assessment
|
|
Concept
|
Cross-Over Studies
|
|
Concept
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors
|
|
Concept
|
Drug Delivery Systems
|
|
Concept
|
Natriuretic Peptide, Brain
|
|
Concept
|
Pinacidil
|
|
Concept
|
Drug Costs
|
|
Concept
|
Stroke
|
|
Concept
|
Intracranial Hemorrhages
|
|
Concept
|
Calcium Channels, L-Type
|
|
Concept
|
Calcium Channels, T-Type
|
|
Concept
|
Mibefradil
|
|
Concept
|
Pulmonary Disease, Chronic Obstructive
|
|
Concept
|
Mesalamine
|
|
Concept
|
Pain
|
|
Concept
|
Pressure
|
|
Concept
|
Guideline Adherence
|
|
Concept
|
Product Surveillance, Postmarketing
|
|
Concept
|
Propanolamines
|
|
Concept
|
Propranolol
|
|
Concept
|
Tetrahydroisoquinolines
|
|
Concept
|
Prospective Studies
|
|
Concept
|
Receptor, Angiotensin, Type 2
|
|
Concept
|
Receptor, Angiotensin, Type 1
|
|
Concept
|
Metabolic Syndrome
|
|
Concept
|
Trans Fatty Acids
|
|
Concept
|
Sodium Channel Blockers
|
|
Concept
|
Pulmonary Edema
|
|
Concept
|
Pulmonary Fibrosis
|
|
Concept
|
Shock, Cardiogenic
|
|
Concept
|
Sinus of Valsalva
|
|
Concept
|
Renal Insufficiency
|
|
Concept
|
Triazines
|
|
Concept
|
Trimetazidine
|
|
Concept
|
Ultrasonography
|
|
Concept
|
United States
|
|
Concept
|
United States Food and Drug Administration
|
|
Concept
|
United States Department of Veterans Affairs
|
|
Concept
|
Serpins
|
|
Concept
|
Comorbidity
|
|
Concept
|
Thrombolytic Therapy
|
|
Concept
|
Estrogen Replacement Therapy
|
|
Concept
|
Body Mass Index
|
|
Concept
|
Incidence
|
|
Concept
|
Prevalence
|
|
Concept
|
Survival Rate
|
|
Concept
|
Multivariate Analysis
|
|
Concept
|
Chi-Square Distribution
|
|
Concept
|
Linear Models
|
|
Concept
|
Logistic Models
|
|
Concept
|
Proportional Hazards Models
|
|
Concept
|
Odds Ratio
|
|
Concept
|
Randomized Controlled Trials as Topic
|
|
Concept
|
Single-Blind Method
|
|
Concept
|
Walking
|
|
Concept
|
Databases, Factual
|
|
Concept
|
Angina, Stable
|
|
Concept
|
Angiotensin II Type 1 Receptor Blockers
|
|
Concept
|
Ventricular Function
|
|
Concept
|
Ventricular Function, Left
|
|
Concept
|
Sex Distribution
|
|
Concept
|
Lisinopril
|
|
Concept
|
Hospital Costs
|
|
Concept
|
Drug Utilization Review
|
|
Concept
|
Osteoprotegerin
|
|
Concept
|
1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine
|
|
Concept
|
Atherosclerosis
|
|
Concept
|
Area Under Curve
|
|
Concept
|
Acute Coronary Syndrome
|
|
Concept
|
Angiotensin Receptor Antagonists
|
|
Concept
|
Healthcare Disparities
|
|
Concept
|
Recommended Dietary Allowances
|
|
Concept
|
Cyclic Nucleotide Phosphodiesterases, Type 5
|
|
Concept
|
Coronary Restenosis
|
|
Concept
|
Cardiac Resynchronization Therapy
|
|
Concept
|
Kaplan-Meier Estimate
|
|
Concept
|
Time-to-Treatment
|
|
Concept
|
Percutaneous Coronary Intervention
|
|
Concept
|
Aorta, Abdominal
|
|
Concept
|
Aorta, Thoracic
|
|
Concept
|
Aortic Rupture
|
|
Concept
|
Aortic Valve
|
|
Concept
|
Coronary Artery Bypass
|
|
Concept
|
Arousal
|
|
Concept
|
Arrhythmias, Cardiac
|
|
Concept
|
Arteriovenous Fistula
|
|
Concept
|
Arthritis, Rheumatoid
|
|
Concept
|
Aspirin
|
|
Concept
|
Atenolol
|
|
Concept
|
Atrial Fibrillation
|
|
Concept
|
Atropine
|
|
Concept
|
Autopsy
|
|
Concept
|
Intracranial Embolism and Thrombosis
|
|
Concept
|
Chest Pain
|
|
Concept
|
Chlorthalidone
|
|
Concept
|
Diastole
|
|
Concept
|
Dietary Fats
|
|
Concept
|
Diethylstilbestrol
|
|
Concept
|
Digoxin
|
|
Concept
|
Dihydroalprenolol
|
|
Concept
|
Disopyramide
|
|
Concept
|
Diuretics
|
|
Concept
|
Dobutamine
|
|
Concept
|
Follow-Up Studies
|
|
Concept
|
Hypertension, Pulmonary
|
|
Concept
|
Hypoglycemia
|
|
Concept
|
Imidazoles
|
|
Concept
|
Indoramin
|
|
Concept
|
Metabolic Clearance Rate
|
|
Concept
|
Methods
|
|
Concept
|
Organ Size
|
|
Concept
|
Ovariectomy
|
|
Concept
|
Oxprenolol
|
|
Academic Article
|
Lack of arrhythmogenicity with ST-segment elevation during high-dose of dobutamine atropine stress in patients with documented or suspected coronary artery disease.
|
|
Academic Article
|
Effect of 17-beta estradiol in the rabbit: endothelium-dependent and -independent mechanisms of vascular relaxation.
|
|
Academic Article
|
Management Strategies and Outcomes of ST-Segment Elevation Myocardial Infarction Patients Transferred After Receiving Fibrinolytic Therapy in the United States.
|
|
Academic Article
|
Management of Stable Angina - Current Guidelines: A Critical Appraisal.
|
|
Academic Article
|
Trans fatty acids linked to myocardial infarction and stroke: What is the evidence?
|
|
Academic Article
|
Stable Angina Medical Therapy Management Guidelines: A Critical Review of Guidelines from the European Society of Cardiology and National Institute for Health and Care Excellence.
|
|
Academic Article
|
Cardiac tamponade, constrictive pericarditis and pericardial resection in rheumatoid arthritis.
|
|
Academic Article
|
Pulmonary veno-occlusive disease.
|
|
Academic Article
|
Aortic valve incompetence and replacement in rheumatoid arthritis.
|
|
Academic Article
|
Role of nitrates in angina pectoris.
|
|
Academic Article
|
Rheumatoid lung disease with pulmonary fibrosis necrobiotic nodules and pleural effusion.
|
|
Academic Article
|
Lignocaine therapy for ventricular ectopic activity after acute myocardial infarction: a double-blind trial.
|
|
Academic Article
|
Plasma cortisol, urinary 17-hydroxycorticoids, and urinary vanilyl mandelic acid after acute myocardial infarction.
|
|
Academic Article
|
Profunda femoral arteriovenous fistula after percutaneous arterial and venous catheterization.
|
|
Academic Article
|
Pericarditis after acute myocardial infarction.
|
|
Academic Article
|
Comparison of five beta-adrenoreceptor antagonists with different ancillary properties during sustained twice daily therapy in angina pectoris.
|
|
Academic Article
|
Beta blockers in hypertension.
|
|
Academic Article
|
Ointments and transdermal nitroglycerin patches for stable angina pectoris.
|
|
Academic Article
|
Amlodipine in chronic stable angina: results of a multicenter double-blind crossover trial.
|
|
Academic Article
|
Ovariectomy and estrogen-induced alterations in myocardial contractility in female rabbits: role of the L-type calcium channel.
|
|
Academic Article
|
Treatment of stable angina.
|
|
Academic Article
|
Comparison of pharmacokinetics of lanoteplase and alteplase during acute myocardial infarction.
|
|
Academic Article
|
Effects of angiotensin-converting enzyme inhibition on transient ischemia: the Quinapril Anti-Ischemia and Symptoms of Angina Reduction (QUASAR) trial.
|
|
Academic Article
|
Prevention of nitrate tolerance with angiotensin II receptor type 1 blocker in patients with stable angina: yet another failed strategy to prevent tolerance.
|
|
Academic Article
|
Modified-release formulation of trimetazidine for exceptional control of angina pectoris: fact or fiction.
|
|
Academic Article
|
Side effects of using nitrates to treat heart failure and the acute coronary syndromes, unstable angina and acute myocardial infarction.
|
|
Academic Article
|
Low-dose aspirin for primary prevention of cardiovascular events in patients with diabetes: a meta-analysis.
|
|
Academic Article
|
Pigment epithelial-derived factor and acute coronary syndrome: a novel protective biomarker but not for routine clinical use at present.
|
|
Academic Article
|
Temporal Trends of Digoxin Use in Patients Hospitalized With Heart Failure: Analysis From the American Heart Association Get With The Guidelines-Heart Failure Registry.
|
|
Academic Article
|
Prognostic Value of 6-Minute Walk Distance in Patients Undergoing Percutaneous Coronary Intervention: a Veterans Affairs Prospective Study.
|
|
Academic Article
|
Utilization of guideline-directed medical therapy in patients with de novo heart failure with reduced ejection fraction: A Veterans Affairs study.
|
|
Academic Article
|
Nitrate tolerance. How to prevent it or minimize its effect.
|
|
Academic Article
|
Nitrate therapy for myocardial ischemic syndrome: current perspectives including tolerance.
|
|
Academic Article
|
Transdermal nitroglycerin patches in angina pectoris. Dose titration, duration of effect, and rapid tolerance.
|
|
Academic Article
|
The effectiveness of transcutaneous nitrate preparations for angina pectoris.
|
|
Academic Article
|
Nitrate therapy: continuous or pulse dosing.
|
|
Academic Article
|
Relationship of pharmacokinetic and pharmacodynamic properties of the organic nitrates.
|
|
Academic Article
|
Interaction of indomethacin and nitroglycerin on hemodynamics and exercise tolerance in patients with angina pectoris.
|
|
Academic Article
|
Nitrates for angina pectoris. A critical review of therapeutic efficacy and tolerance.
|
|
Academic Article
|
Tolerance to the circulatory effects of oral isosorbide dinitrate. Rate of development and cross-tolerance to glyceryl trinitrate.
|
|
Academic Article
|
Double-blind efficacy and safety study of a novel anti-ischemic agent, ranolazine, versus placebo in patients with chronic stable angina pectoris. Ranolazine Study Group.
|
|
Academic Article
|
Lack of pharmacologic tolerance and rebound angina pectoris during twice-daily therapy with isosorbide-5-mononitrate.
|
|
Academic Article
|
Influence of glyceryl trinitrate during supine and upright exercise in patients with angina pectoris.
|
|
Academic Article
|
Ricin disturbs calcium homeostasis in the rabbit heart.
|
|
Academic Article
|
Efficacy and safety of fasudil in patients with stable angina: a double-blind, placebo-controlled, phase 2 trial.
|
|
Academic Article
|
Long-term bepridil monotherapy for angina pectoris.
|
|
Academic Article
|
Metabolic and clinical outcomes in nondiabetic individuals with the metabolic syndrome assigned to chlorthalidone, amlodipine, or lisinopril as initial treatment for hypertension: a report from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).
|
|
Academic Article
|
Noninvasive evaluation of aortic stenosis severity utilizing Doppler ultrasound and electrical bioimpedance.
|
|
Academic Article
|
Effects of 1-epinephrine on hemodynamics and cardiac function in coronary disease: dose-response studies.
|
|
Academic Article
|
Mechanisms of myocardial ischemia induced by epinephrine: comparison with exercise-induced ischemia.
|
|
Academic Article
|
Improvement in angina pectoris with alpha adrenoceptor blockade.
|
|
Academic Article
|
Quantification of aortic regurgitation utilizing continuous wave Doppler ultrasound.
|
|
Academic Article
|
Nitrates as an integral part of optimal medical therapy and cardiac rehabilitation for stable angina: review of current concepts and therapeutics.
|
|
Academic Article
|
Isosorbide-5-mononitrate in angina pectoris: plasma concentrations and duration of effects after acute therapy.
|
|
Academic Article
|
Is risk factor control and guideline-based medical therapy optimal in patients with nonobstructive coronary artery disease? A Veterans Affairs study.
|
|
Academic Article
|
Usefulness of twice-daily isosorbide-5-mononitrate in preventing development of tolerance in angina pectoris.
|
|
Academic Article
|
Obesity, brain natriuretic peptide levels and mortality in patients hospitalized with heart failure and preserved left ventricular systolic function.
|
|
Academic Article
|
Challenges with nitrate therapy and nitrate tolerance: prevalence, prevention, and clinical relevance.
|
|
Academic Article
|
Hemodynamic effects of disopyramide at rest and during exercise in normal subjects.
|
|
Academic Article
|
Invasive strategy in acute coronary syndrome.
|
|
Academic Article
|
Kinetics of isosorbide dinitrate and relationships to pharmacological effects.
|
|
Academic Article
|
Are the clinical and hemodynamic events during exercise stress testing in invasive studies in patients with angina pectoris reproducible?
|
|
Academic Article
|
Oral isosorbide dinitrate in the treatment of angina pectoris. Dose-response relationship and duration of action during acute therapy.
|
|
Academic Article
|
Trimetazidine for stable and unstable ischemic heart diseases and for heart failure: Is its routine use justified from available data?
|
|
Academic Article
|
Secondary preventive potential of nitrates in ischaemic heart disease.
|
|
Academic Article
|
Additional antianginal and anti-ischemic efficacy of mibefradil in patients pretreated with a beta blocker for chronic stable angina pectoris.
|
|
Academic Article
|
Supersensitivity to serotonin- and histamine-induced arterial contraction following ovariectomy.
|
|
Academic Article
|
The effect of vardenafil, a potent and highly selective phosphodiesterase-5 inhibitor for the treatment of erectile dysfunction, on the cardiovascular response to exercise in patients with coronary artery disease.
|
|
Academic Article
|
Selection of optimal therapy for chronic stable angina.
|
|
Academic Article
|
Clinical events in high-risk hypertensive patients randomly assigned to calcium channel blocker versus angiotensin-converting enzyme inhibitor in the antihypertensive and lipid-lowering treatment to prevent heart attack trial.
|
|
Academic Article
|
Isosorbide dinitrate/hydralazine: its role in the treatment of heart failure.
|
|
Academic Article
|
Anemia and associated clinical outcomes in patients with heart failure due to reduced left ventricular systolic function.
|
|
Academic Article
|
A comparative study of the activity of beta-adrenoceptor antagonists in man.
|
|
Academic Article
|
Slow release oxprenolol in angina pectoris [proceedings].
|
|
Academic Article
|
Propranolol in angina pectoris: duration of improved exercise tolerance and circulatory effects after acute oral administration.
|
|
Academic Article
|
Effects of glucose-insulin-potassium infusion on the angina response during treadmill exercise.
|
|
Academic Article
|
Clinical, hemodynamic and metabolic responses during pacing in the supine and sitting postures in patients with angina pectoris.
|
|
Academic Article
|
Cardiac performance at rest and during exercise in normal subjects.
|
|
Academic Article
|
Comparison of the immediate effects of five beta-adrenoreceptor-blocking drugs with different ancillary properties in angina pectoris.
|
|
Academic Article
|
Hemodynamics at rest and during supine and sitting bicycle exercise in normal subjects.
|
|
Academic Article
|
Propranolol in the treatment of angina pectoris. Comparison of duration of action in acute and sustained oral therapy.
|
|
Academic Article
|
Massive splenomegaly, pancytopenia and haemolytic anaemia in sarcoidosis.
|
|
Academic Article
|
Hemodynamics at rest and during supine and sitting bicycle exercise in patients with coronary artery disease.
|
|
Academic Article
|
Oxprenolol in angina pectoris [proceedings].
|
|
Academic Article
|
Congenital intrapericardial aneurysms of the left atrium.
|
|
Academic Article
|
Clinically silent atrial septal defects with evidence for cerebral embolization.
|
|
Academic Article
|
Rupture of abdominal aortic aneurysm during exercise. Gated blood pool studies.
|
|
Academic Article
|
Atenolol for ventricular ectopy: a dose-response study.
|
|
Academic Article
|
Doppler echocardiographic profiles in obstructive right and left atrial myxomas.
|
|
Academic Article
|
Duration of effects and tolerance of slow-release isosorbide-5-mononitrate for angina pectoris.
|
|
Academic Article
|
Comparative efficacy of 200, 300 and 400 mg of bepridil for chronic stable angina pectoris.
|
|
Academic Article
|
Comparison of adrenergic beta-receptor antagonists in angina pectoris.
|
|
Academic Article
|
Cardiovascular effects of weight reduction in obese patients with angina pectoris.
|
|
Academic Article
|
Proceedings: Left ventricular pressure-volume changes during exercise-induced pain in patients with angina pectoris.
|
|
Academic Article
|
Myocardial infarct artery patency and reocclusion rates after treatment with duteplase at the dose used in the International Study of Infarct Survival-3. Burroughs Wellcome Study Group.
|
|
Academic Article
|
Management of patients with chronic stable angina at low risk for serious cardiac events.
|
|
Academic Article
|
Effect of Obesity on Response to Spironolactone in Patients With Heart Failure With Preserved Ejection Fraction.
|
|
Academic Article
|
Proceedings: Comparison of antihypertensive effectiveness of beta-adrenoceptor antagonists with different pharmacological properties.
|
|
Academic Article
|
Comparative anti-hypertensive effectiveness of beta-adrenoreceptor antagonists with different pharmacological properties: dose-response studies during acute and chronic administration.
|
|
Academic Article
|
Polypills: Common garden variety or precision formulated for improving cardiovascular outcomes: An ongoing challenge.
|